VARIATIONS IN ONCOLYTIC ACTIVITY OF HUMAN SERUM

[1] BOLANDE RP, 1960, LAB INVEST, V9, P475

[2] FISCHEL EE, 1953, J CLIN INVEST, V32, P568

[3] FREUND E, 1910, WIENER KLINISCHE WOC, V23, P1221

[4] GINSBURG I, 1961, P SOC EXP BIOL MED, V107, P235

[5] SURVIVAL TIME OF MICE WITH EHRLICHS ASCITES CARCINOMA RELATED TO SEX AND WEIGHT OF MOUSE, AND BLOOD CONTENT OF TUMOUR [J]. BRITISH JOURNAL OF CANCER, 1961, 15 (02) : 336 - &

[6] HARTVEIT F, IN PRESS

[7] KABAT EA, 1961, EXPERIMENTAL IMMUNOC

[8] KRAUS R, 1912, WIEN KLIN WSCHR, V25, P867

[9] KURU M, 1959, ACTA UNION INT CONTR, V15, P165

[10] MCGHEE RB, 1952, P SOC EXP BIOL MED, V80, P419, DOI 10.3181/00379727-80-19642

[1] BOLANDE RP, 1960, LAB INVEST, V9, P475

[2] FISCHEL EE, 1953, J CLIN INVEST, V32, P568

[3] FREUND E, 1910, WIENER KLINISCHE WOC, V23, P1221

[4] GINSBURG I, 1961, P SOC EXP BIOL MED, V107, P235

[5] SURVIVAL TIME OF MICE WITH EHRLICHS ASCITES CARCINOMA RELATED TO SEX AND WEIGHT OF MOUSE, AND BLOOD CONTENT OF TUMOUR [J]. BRITISH JOURNAL OF CANCER, 1961, 15 (02) : 336 - &

[6] HARTVEIT F, IN PRESS

[7] KABAT EA, 1961, EXPERIMENTAL IMMUNOC

[8] KRAUS R, 1912, WIEN KLIN WSCHR, V25, P867

[9] KURU M, 1959, ACTA UNION INT CONTR, V15, P165

[10] MCGHEE RB, 1952, P SOC EXP BIOL MED, V80, P419, DOI 10.3181/00379727-80-19642